Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print More older women are retaining 'young' breasts causing potential screening problems

More older women are retaining 'young' breasts causing potential screening problems

March 14, 2004

Many of today's generation of postmenopausal women have breast tissue more akin to that of younger women. This makes it harder for mammograms to pick up tumours or early signs of breast cancer in some over 50s and may also lead to unnecessary biopsies because of uncertainty in reading the results, a meeting of screening specialists will hear today (Tuesday 16 March).

Mammogram samples from a screening programme in the Netherlands showed that a quarter of women aged 50 to 69 had the 'dense'[1] mammographic breast patterns more normally associated with younger women. Among 50 to 54-year-olds the proportion was 44%.




Radiologist Dr Fred van der Horst said no one really knew why the change had occurred. It was unlikely to be due entirely to HRT as its use never exceeded 15% in the Netherlands. But, it could partly be due to the changes in childbearing patterns.

Dr van der Horst will be presenting the findings at the 4th European Breast Cancer Conference to a special meeting of the European Group for Breast Cancer Screening.

He said that breast cancer screening in postmenopausal women is effective but cancers can still go undetected. High mammographic density partly accounted for these missed cancers.

The study set out to see what impact breast density had on screening performance. Researchers chose a random sample of 2,000 from among the 54,500 women who are screened every two years in a screening programme. They classified the mammograms as dense if more than a quarter of the breast was composed of dense tissue. If less than a quarter of the breast comprised dense tissue the mammograms were classified as lucent[1].

They found that 25% of 50 to 69-year-olds overall had dense breasts - 44% of 50 to 54-year-olds reducing to 17% of 65 to 69-year-olds. They then calculated the ratio of screen-detected cancers to the total number of screen-detected cancers plus those cancers arising in the interval between screening, to estimate the sensitivity of the mammograms i.e. the ability of the mammogram to detect cancer accurately in those women that had it. In the dense group it was only 59% compared to 67% in the lucent group.

Dr van der Horst, a radiologist in the National Training and Expert Centre for Breast Cancer Screening in Nijmegen, said the difference in sensitivity between the two groups indicated the size of the potential problem.

"I don't think the problem of women referred on because of uncertainties over dense breasts is that big in the Netherlands as there is a low referral rate. But, if larger numbers of women are referred on, then the probability of referrals that turn out to be unnecessary in hindsight will increase, and the risk of unnecessary referral will be higher for those with dense breasts.                                         

"However, it is difficult to disentangle the factors that play a part in referral as the chance of having breast cancer diagnosed increases with age anyway while the lower incidence in younger women is in itself a reason for a mammogram having a less certain predictive value."

Dr van der Horst said it was unlikely that HRT played more than a part in the fact that today's postmenopausal women had denser breasts than their counterparts 20 years ago.

"In the study group HRT use was under 10% in the perimenopausal period (the few years leading up to the menopause) and almost non-existent in the eldest group. In the Netherlands generally, HRT use has never been more than 15%. We know that women who have given birth have more lucent breasts than childless women. It's possible that demographic changes such as women having fewer children than 30 years ago and having them at a later age may play a role."

Can anything be done to improve screening detection in women with dense breast tissue? Dr van der Horst said there had been some research hinting that adding ultrasound to mammography could improve cancer detection in women with dense breasts, but there was not enough information to warrant its introduction on a large scale for screening purposes. There was a general consensus that in the under 50s there should be at most a year between screenings. It was possible that the current two-year screening interval for women between 50 and 55 was not optimal. However, more frequent screening in a population-based screening programme would influence cost-effectiveness and necessitate political choices.
(ends)

Abstract no: 18 (The European Group for Breast Cancer Screening meeting is from 09.00 to 17.00 hrs in Hall 1).

Note:
[1] Dense tissue is glandular and shows white on mammograms. Lucent tissue is fat and shows black. The difficulty with dense tissue is that the white areas on mammograms may conceal possible cancer. Ultrasound acts the opposite way, showing cancerous tissue as black. In general women's breast tissue becomes more lucent as they age, especially if the have had children, although the denser a woman's tissue is when she is young the longer it takes to become lucent.

MW Communications



Related Breast Cancer Current Events and Breast Cancer News Articles Breast Cancer Current Events and Breast Cancer News RSS Breast Cancer Current Events and Breast Cancer News RSS
Researchers Identify Role of Gene in Tumor Development, Growth and Progression
Virginia Commonwealth University Massey Cancer Center and VCU Institute of Molecular Medicine researchers have identified a gene that may play a pivotal role in two processes that are essential for tumor development, growth and progression to metastasis.

UCLA researchers create 'fly paper' to capture circulating cancer cells
Just as fly paper captures insects, an innovative new device with nano-sized features developed by researchers at UCLA is able to grab cancer cells in the blood that have broken off from a tumor.

Fertility procedures need not delay breast cancer treatment for younger women
A new study published in the November issue of the Journal of the American College of Surgeons shows that breast cancer patients under 40 years old who undergo fertility preservation do not face a significant delay in the treatment of their disease when their care is coordinated in a timely fashion.

Coffee break: Compound brewing new research in colon, breast cancer
A compound in coffee has been found to be estrogenic in studies by Texas AgriLife Research scientists.

Drugs to treat anemia in cancer patients linked to thromboembolism
Medications frequently given to cancer patients to reduce their risk of anemia are associated with an increased risk of deep vein thrombosis or pulmonary embolism, according to new research led by Dawn Hershman, M.D, M.S., co-director of the breast cancer program at the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian Hospital/Columbia University Medical Center.

Discovery in worms by Queen's researchers points to more targeted cancer treatment
Researchers at Queen's University have found a link between two genes involved in cancer formation in humans, by examining the genes in worms. The groundbreaking discovery provides a foundation for how tumor-forming genes interact, and may offer a drug target for cancer treatment.

FDA approved leukemia drugs shows promise in ovarian cancer cells
The drug Sprycel, approved for use by the U.S. Food and Drug Administration in patients with chronic myeloid leukemia, significantly inhibited the growth and invasiveness of ovarian cancer cells and also promoted their death, a study by researchers with UCLA's Jonsson Comprehensive Cancer Center found.

Carnegie Mellon researchers link health-care debate to risk of dying in US and Europe
The current health care debate in the United States is complicated. Trade-offs between heath care expenditures, lifestyle choices and life expectancy have been suggested but seldom clearly demonstrated.

Scientists uncover new key to the puzzle of hormone therapy and breast cancer
The use of postmenopausal hormone therapy has decreased over time in the United States, which researchers suggest may play a key role in the declining rate of atypical ductal hyperplasia, a known risk factor for breast cancer.

Breast density associated with increased risk of cancer recurrence
A new study finds that women treated for breast cancer are at higher risk of cancer recurrence if they have dense breasts. Published in the December 15, 2009 issue of Cancer, a peer-reviewed journal of the American Cancer Society, the study's results indicate that breast cancer patients with dense breasts may benefit from additional therapies following surgery, such as radiation.
More Breast Cancer Current Events and Breast Cancer News Articles
New Balance Women's Lace Up X Out Breast Cancer Tech Tee (Athletic Grey, Small)

New Balance Women's Lace Up X Out Breast Cancer Tech Tee (Athletic Grey, Small)
by New Balance

The New Balance X Out Breast Caner Tee has a soft hand and clearly states how everyone feels!

1149 WOMENS VINTAGE BLACK ADJUSTABLE FATIGUE CAP w/PINK STRIPES & ''BREAST CANCER'' RIBBON

1149 WOMENS VINTAGE BLACK ADJUSTABLE FATIGUE CAP w/PINK STRIPES & ''BREAST CANCER'' RIBBON
by Rothco

A portion of these proceeds go to the Babylon Breast Cancer Coalition- For Life, For Hope, For Change, For the Future Visit www.babylonbreastcancer.org for more information.

Breast Cancer Survival Manual, Fourth Edition: A Step-by-Step Guide for the Woman With Newly Diagnosed Breast Cancer

Breast Cancer Survival Manual, Fourth Edition: A Step-by-Step Guide for the Woman With Newly Diagnosed Breast Cancer
by John Link (Author)

A completely updated edition of the definitive guide for patients with breast cancer
The new fourth edition of The Breast Cancer Survival Manual provides essential updates on treatment and care, enhancing the basic information that has made this the most trusted guide for women diagnosed with breast cancer for the past decade. This edition includes the most current advice on • getting a second opinion: why it’s important, what questions    to ask, and how to decide which team of doctors is best for you
• updates on genetic testing and how doctors are using
   the results to tailor care for each patient
• navigating new types of radiation, the herceptin
   breakthrough, and improved reconstruction surgeries
Conscious of the rapidly evolving spectrum of...

Sunbeam SlumberRest Camelot Microplush Heated Throw, Breast Cancer Awareness Pink

Sunbeam SlumberRest Camelot Microplush Heated Throw, Breast Cancer Awareness Pink
by Sunbeam

Soft comfortable fabric that you can cuddle up with anywhere in your house. Use it on the couch while curling up to read a good book or in a chair while watching your favorite show. This throw is 50"x60", with a primstyle control which features 3 warming settings and 3 hour auto-off. So turn on your warming blanket, turn off your thermostat and save on your heating bill. Warm up to a good cause! Sunbeam is joining the fight against breast cancer. Through the purchase of this pink throw, sunbeam will donate $1.00 to city of hope for breast cancer research, treatment and education* up to $25,000. Program ends april 30, 2009. "to save lives and end breast cancer forever by empowering people, ensuring quality care for all, and energizing science to find the cures." *to learn more about...

Hope Courage Strength Pink Ribbon Breast Cancer Awareness Expressively Yours Bracelet

Hope Courage Strength Pink Ribbon Breast Cancer Awareness Expressively Yours Bracelet
by MyJewelThief



Wrangler Women's Tough Enough To Wear Pink Breast Cancer Awareness Jacket,Pink,X-Large

Wrangler Women's Tough Enough To Wear Pink Breast Cancer Awareness Jacket,Pink,X-Large
by Wrangler

Are you tough enough to wear pink? That is the question the western industry asked 12/9/05 at the Wrangler National Finals Rodeo (Wrangler NFR), the "Super Bowl of pro rodeo," as it launched Tough Enough to Wear Pink (TETWP). TETWP is a multi-year, western-industry-wide fundraiser to raise awareness and funds for breast cancer research. TETWP partners are ponying up to support this cause by manufacturing pink merchandise with proceeds benefiting breast cancer research. By wearing this Tough Enough to Wear Pink shirt you are helping in the fight against breast cancer. This TETWP shirt is a pink cotton plaid. Import. Tough Enough to Wear Pink. long sleeve zip front jacket with zippered front slash pockets and the breast cancer embroidery on left chest. 100% Polyester Fleece/100% Nylon...

Just Get Me Through This!: The Practical Guide to Breast Cancer

Just Get Me Through This!: The Practical Guide to Breast Cancer
by Deborah A. Cohen (Author), M.D., Robert M. Gelfand (Author)



Find the Cure Pink Breast Cancer Awareness Wristband

Find the Cure Pink Breast Cancer Awareness Wristband
by sci

Find The Cure Pink Breast Cancer Awareness wristband

Raymond Geddes National Breast Cancer Foundation Pen (67709)

Raymond Geddes National Breast Cancer Foundation Pen (67709)
by Raymond Geddes

Breast Cancer Awareness Pen, Join Geddes in supporting the National Breast Cancer Foundation and the fight against Breast Cancer. Assortment contains pink pens with pink ribbons. Retractable, black in pen ink. 5 1/2" long.

Thermos Intak Breast Cancer Awareness 26-Ounce Hydration Bottle

Thermos Intak Breast Cancer Awareness 26-Ounce Hydration Bottle
by Thermos Nissan

Thermos Intak breast cancer awareness hydration bottle is made from bpa free, impact- resistant, dishwasher durable eastman tritan copolyester. The leak-proof lid has an integrated carrying loop. Ideal for water, iced tea, juices and sports drinks: tritan material will not retain flavors or odors of liquid contents. Thermos will donate 3-percent of pink ribbon sales to support breast cancer initiatives.

© 2009 BrightSurf.com